Although cefoperazone is relatively stable to staphylococcal 1-lactamases and to most chromosomally mediated P-lactamases from gram-negative bacilli, it can be hydrolyzed by some plasmid-mediated P-lactamases that may be produced by members of the family Enterobacteriaceae (6, 9, 11). Cephalosporinases produced by most members of the Bacteroides fragilis group will also hydrolyze cefoperazone (1, 3, 4). The spectrum of useful antibacterial activity of cefoperazone may be expanded when it is combined with a ,-lactamase inhibitor (6, 9, 11). Sulbactam is a penicillinic acid sulfone with limited antibacterial activity but with the ability to irreversibly bind with many ,-lactamase enzymes (5). In the presence of sulbactam, the antibacterial activity of cefoperazone should be expanded to include most anaerobic bacteria and many of the P-lactamase-producing enteric bacilli that are endemic in some institutions. 
P-lactamases from gram-negative bacilli, it can be hydrolyzed by some plasmid-mediated P-lactamases that may be produced by members of the family Enterobacteriaceae (6, 9, 11) . Cephalosporinases produced by most members of the Bacteroides fragilis group will also hydrolyze cefoperazone (1, 3, 4) . The spectrum of useful antibacterial activity of cefoperazone may be expanded when it is combined with a ,-lactamase inhibitor (6, 9, 11) . Sulbactam is a penicillinic acid sulfone with limited antibacterial activity but with the ability to irreversibly bind with many ,-lactamase enzymes (5) . In the presence of sulbactam, the antibacterial activity of cefoperazone should be expanded to include most anaerobic bacteria and many of the P-lactamase-producing enteric bacilli that are endemic in some institutions.
Cefoperazone and sulbactam have been combined for parenteral administration, and we have been concerned with the question of how in vitro susceptibility tests should be performed with that combination. In a previous report (8) , we concluded that for broth or agar dilution tests, 2 parts cefoperazone should be combined with 1 part sulbactam. In the present report, we confirm the utility of this 2:1 ratio and also define quality control guidelines for broth microdilution susceptibility tests and for anaerobic agar dilution tests. In addition, studies were performed to define disk content, interpretive criteria, and quality control guidelines for the disk diffusion susceptibility tests. The results of tests with A. calcoaceticus isolates are summarized in Table 3 . All 21 isolates were susceptible to sulbactam alone (MIC, 1.0 to 4.0 ,ug/ml) but were relatively resistant to cefoperazone alone (MIC, -16 ,ug/ml). When combined with 4.0 or 8.0 ,ug of sulbactam per ml, all 21 isolates appeared to be inhibited by sO.12 ,ug of cefoperazone per ml, but inhibition was solely due to the sulbactam component of the combination. When the two drugs were tested in a 2:1 ratio of cefoperazone to sulbactam, the combination was only slightly more active than with the sulbactam alone. Disk diffusion susceptibility tests were also performed with the 21 A. calcoaceticus isolates. The average zone diameter around 75-p.g cefoperazone disks was 16.2 mm, and 15-pug sulbactam disks produced zones averaging 27.5 mm. When 15 ,ug of sulbactam was added to a 75-ktg cefoperazone disk, the average zone diameter was 26.9 mm (essentially the same as with disks containing sulbactam alone). When 30 ,ug of sulbactam was added to a 75-,ug cefoperazone disk, the mean zone diameter was even larger (29.8 mm).
Quality control parameters of 75/30-,ug cefoperazone-sulbactam disks are summarized in Table 4 . The control strains of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa were minimally affected by the presence of sulbactam in the disks, i.e., zones around 75/30-,ug cefoperazonesulbactam disks were generally 1 mm smaller than those around 75-,ug cefoperazone disks. A single lot of 75-,ug cefoperazone disks was included in the present study, and the results were identical to those obtained in the original 1981 study (10) . The minor differences in zone size might only represent small differences in the potency of the cefoperazone component of the disks, i.e., the sulbactam component did not appear to influence the zone size very much, if at all. A. calcoaceticus subsp. anitratus ATCC 43498 was susceptible to the sulbactam in the combination but produced relatively small (14 to 18 mm) zones with cefoperazone disks. Zone size limits of 26 to 32 mm should apply to tests with 75/30-,ug cefoperazone-sulbactam disks.
For monitoring the performance of broth microdilution tests, five different control strains were evaluated (Table 5) . A. calcoaceticus subsp. anitratus ATCC 43498 was again found to be susceptible to the combination but was resistant to cefoperazone alone. For the other strains, control limits that are being used for cefoperazone can be applied to tests with the cefoperazone-sulbactam combination. For the ref- bacterial growth. Consequently, the concentration of sulbactam in the blood of patients several hours after administration of the combination may be important only when the coadministered drug fails to inhibit additional 1-lactamase production by the microorganisms. For that reason, the serum half-lives of the drugs may not be as relevant as the peak tissue levels when selecting appropriate combinations for in vitro testing. One may simply add a concentration of inhibitor which would be expected at the site of infection shortly after intravenous administration (4.0 or 8.0 ,ug/ml).
Alternatively, one may test a fixed ratio which contains the two drugs in the proportions that are found in the blood of the patient shortly after the combination is administered. We elected to test 2 parts cefoperazone combined with 1 part sulbactam because that ratio resembles the expected levels in blood shortly after administration. The half-life of cefoperazone is much longer than that of sulbactam and thus the ratios will change with time. ,ug of sulbactam per ml) (8) . However, sulbactam-susceptible species such as the Acinetobacter spp. are best tested with a fixed 2:1 ratio because excessive amounts of inhibitor are not included with the lower concentrations of cefoperazone. On the other hand, when a fixed ratio is tested, wells containing >32 ,ug of cefoperazone per ml might contain pharmacokinetically unrealistic amounts of sulbactam.
To control susceptibility tests with drug combinations, it is necessary to monitor the performance of both components. For example, when monitoring tests with trimethoprimsulfamethoxazole, the combination is more active than either drug alone and thus a loss of potency of either drug should be detected by the results of standard control tests.
,-Lactamase inhibitors do not affect the activity of the standard control strains. For control of clavulanic acid combined with amoxicillin or ticarcillin, a type TMa IPlactamase-producing strain, E. coli ATCC 35218, has been recommended by the NCCLS (12, 13, 16) . The strain may also be used for controlling tests with the ampicillin-sulbactam combination. That strain is resistant to the penicillins but susceptible when clavulanic acid or sulbactam is added. Unfortunately, that strain of E. coli is susceptible to cefoperazone alone and cannot be used for monitoring the cefoperazone-sulbactam combination. A control strain of A. calcoaceticus subsp. anitratus ATCC 43498 was selected for monitoring the sulbactam portion of that combination. The established control strains adequately monitored the cefoperazone portion of the combination. For anaerobic dilution tests, B. thetaiotaomicron ATCC 29741 was the most useful control strain. For monitoring tests with cefoperazone alone, B. fragilis ATCC 25285 was also useful. Our MIC control limits were more consistent with the original recommendations of the NCCLS (15), rather than the broader 4-dilution range that was recommended in the 1986 supplement (16) .
For the disk diffusion test, we have previously recommended use of 75/15-,ug disks, but 75/30-ptg disks were not evaluated (9) . In this study, we expanded our previous observations to evaluate both types of disks and concluded that either disk could be used satisfactorily. However, the 75/30-,ug disks provided fewer discrepancies with MIC (2:1 ratio) categories. Quality control limits for tests with 75/30-,ug disks are proposed in this report.
